Globalized Clinical Trials

Abstract The application of globalized clinical trials represents a vast range of genetic variability among the human subjects within the inclusion criteria, naïve population and cost reductions in clinical trials. However, globalized clinical trials deal with multi-faceted ethical implications. Some of the ethical implications include the enrollment process issues, informed consent authenticity, application/compliance of good clinical practices (GCPs), patients’ respect and beneficence, and data security. Beyond the ethical qualms, other overarching challenges inherent in globalized clinical trials are cultural differences, the social constructs, economic implications, and operational concerns. Perhaps, in other to manage global clinical trials successfully and humanely, the ethical, regulatory and social issues within the target audience must be addressed appropriately. Globalized Clinical Trials Subjects’ participants are integral part of any product’s breakthroughs in clinical trials. The availability of human subjects is what makes a globalized clinical trial standards possible. The globalized standards establish a comprehensive project plan

This content is restricted to site members. If you are an existing user, please login. New users may register below.

Existing Users Log In